Lipum AB (publ) has appointed Tobias Helgesson as its new Chief Financial Officer (CFO). He succeeds Marina Norberg, who will remain with the company during a transitional period to ensure continuity and a smooth handover.
Tobias Helgesson holds a bachelor’s degree in business administration from Lund University. He brings over 20 years of professional experience, including more than 11 years in the pharmaceutical industry, having worked for companies such as Pfizer, Sanofi, and Otsuka Pharmaceutical. Tobias has held roles including Business Controller, Financial Controller, Finance Manager, and CFO. Through these positions, he has built a solid foundation of experience and a broad skill set, making him well-equipped for the CFO role at Lipum.
“I am very pleased to join Lipum, which I see as a highly interesting company in an exciting phase. It is truly inspiring to be part of an organization so dedicated to making a difference for patients. I very much look forward to working with the Lipum team,” says Tobias Helgesson.
Marina is leaving Lipum at her own request.
“I’ve had the privilege of working with Marina during my two years at Lipum. Her experience and dedication have made her a highly valued colleague, and I want to extend my sincere thanks to her. At the same time, I’m very pleased to welcome Tobias to Lipum. He brings a broad and valuable skill set, and his experience from various pharmaceutical companies, combined with strong engagement and a hands-on approach, will be an important addition to our team,” says CEO Ola Sandborgh.